PMC:7652766 / 25147-25346 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T19","span":{"begin":49,"end":61},"obj":"Phenotype"}],"attributes":[{"id":"A19","pred":"hp_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":"The risk of applying medication commonly used in hypertension treatments to COVID-19 patients (97, 98) has raised different hypotheses over the issue of invoking a higher expression of ACE2 (99–101)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T130","span":{"begin":0,"end":199},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The risk of applying medication commonly used in hypertension treatments to COVID-19 patients (97, 98) has raised different hypotheses over the issue of invoking a higher expression of ACE2 (99–101)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"960","span":{"begin":185,"end":189},"obj":"Gene"},{"id":"963","span":{"begin":73,"end":75},"obj":"Gene"},{"id":"964","span":{"begin":85,"end":93},"obj":"Species"},{"id":"967","span":{"begin":162,"end":163},"obj":"Gene"},{"id":"968","span":{"begin":49,"end":61},"obj":"Disease"},{"id":"969","span":{"begin":76,"end":84},"obj":"Disease"}],"attributes":[{"id":"A960","pred":"tao:has_database_id","subj":"960","obj":"Gene:59272"},{"id":"A963","pred":"tao:has_database_id","subj":"963","obj":"Gene:6999"},{"id":"A964","pred":"tao:has_database_id","subj":"964","obj":"Tax:9606"},{"id":"A967","pred":"tao:has_database_id","subj":"967","obj":"Gene:351"},{"id":"A968","pred":"tao:has_database_id","subj":"968","obj":"MESH:D006973"},{"id":"A969","pred":"tao:has_database_id","subj":"969","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The risk of applying medication commonly used in hypertension treatments to COVID-19 patients (97, 98) has raised different hypotheses over the issue of invoking a higher expression of ACE2 (99–101)."}